Working… Menu
Trial record 21 of 54 for:    Recruiting Studies | Immune Thrombocytopenia

A Phase 2a Study Evaluating BIVV020 in Adults With Persistent/Chronic Immune Thrombocytopenia (ITP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04669600
Recruitment Status : Recruiting
First Posted : December 17, 2020
Last Update Posted : April 6, 2021
Information provided by (Responsible Party):
Sanofi ( Bioverativ, a Sanofi company )

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2022
Estimated Study Completion Date : December 2023